GGrantScoutHQCreate alert

Grants for Special district governments — Page 4

Current opportunities whose structured applicant data includes Special district governments. Confirm entity definitions, geography, registrations, exclusions and every other condition in the official notice.

373 current opportunities · showing 73–96

OPENArts & Culture

Collections Stewardship

National Endowment for the Humanities

The National Endowment for the Humanities (NEH) Division of Collections & Infrastructure is accepting applications for Collections Stewardship, a program to advance the preservation and availability of physical and digital collections important for research, teaching, and public engagement in th

Deadline
Dec 16, 2026
Funding
Estimated total program funding: $14,000,000
Check fit and official source →
OPENResearch & Science

SEFSC Bluefin Tuna Research Program

DOC NOAA - ERA Production

The objective of the program is to provide a basis for advancing science-based fisheries management for Atlantic bluefin tuna. Such advancement will depend upon improvements in understanding of the fisheries, total abundance, and biology of bluefin tuna, especially regarding the effects of mixing an

Deadline
Jan 1, 2027
Funding
Estimated total program funding: $600,000
Check fit and official source →
OPENEducation

National Parks Business Plan Internship

National Park Service

The National Parks Business Plan Internship (BPI) goal is to jointly administer a graduate-level internship program focused on improving the business management and operational health of our national parks and NPS programs. The internship program should:Provide students with in-depth training on NPS

Deadline
Jan 5, 2027
Funding
Estimated total program funding: $1,700,000
Check fit and official source →
OPENHealth & Medical

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

National Institutes of Health

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations t

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in unders

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $500,000
Check fit and official source →
OPENHealth & Medical

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol poli

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

National Institutes of Health

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research missi

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $499,999
Check fit and official source →
OPENHealth & Medical

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

National Institutes of Health

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, he

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENEducation

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and s

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. NLM seeks applications that further the science of personal health inform

Deadline
Jan 8, 2027
Funding
Up to $250,000
Check fit and official source →
OPENHealth & Medical

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenat

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

National Institutes of Health

This NOFO is a call to action in response to the mental health crisis in the United States. We seek applications that will study methods to increase access to evidence-based interventions and services for youth mental health, including those living in rural areas, inner cities, and other under-resou

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activit

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

National Institutes of Health

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for fundi

Deadline
Jan 8, 2027
Funding
Up to $1,515,000
Check fit and official source →
OPENHealth & Medical

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity Announcement (NOFO) intends to supports studies that are both necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. The NHLBI expects that applications to this NOFO will describe the planned clinical trial and

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptation

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BB

Deadline
Jan 12, 2027
Funding
Estimated total program funding: $4,400,000
Check fit and official source →
OPENHealth & Medical

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

National Institutes of Health

As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First Program), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First Program supported genomic data generating centers. Applicants are encouraged to propose sequen

Deadline
Jan 12, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Title X Family Planning Services Grants

Office of the Assistant Secretary for Health

The Office of Population Affairs (OPA) announces the anticipated availability of funds for Fiscal Year (FY) 2027 grants under the authority of Title X of the Public Health Service Act, Section 1001 (42 U.S.C. §300). This notice solicits applications for projects to provide Title X services throu

Deadline
Jan 12, 2027
Funding
Estimated total program funding: $257,000,000
Check fit and official source →
OPENTechnology & Innovation

National Digital Newspaper Program

National Endowment for the Humanities

The National Endowment for the Humanities (NEH) Division of Collections and Infrastructure is accepting applications for the National Digital Newspaper Program (NDNP). The purpose of this program is to create a national digital resource of historically significant newspapers published between 1690 a

Deadline
Jan 14, 2027
Funding
Estimated total program funding: $3,000,000
Check fit and official source →

Before you apply

Applicant type is only the first screening step. Check location, project purpose, cost share, required partners, registration lead time and the funder’s definition of an eligible entity.